SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients series

被引:13
|
作者
Zampieri, Mattia [1 ,2 ]
Argiro, Alessia [1 ,2 ]
Allinovi, Marco [1 ]
Perfetto, Federico [1 ,3 ]
Cappelli, Francesco [1 ,4 ]
机构
[1] Careggi Univ Hosp, Tuscan Reg Amyloidosis Ctr, Largo Brambilla 3, I-50134 Florence, Italy
[2] Careggi Univ Hosp, Cardiomyopathy Unit, Florence, Italy
[3] Careggi Univ Hosp, IV Internal Med Div, Florence, Italy
[4] Careggi Univ Hosp, Div Intervent Struct Cardiol, Cardiothoracovasc Dept, Florence, Italy
关键词
Amyloidosis; SGLT2i; Heart failure; Diabetes; Empaglifozin; Dapagliflozin; Canagliflozin;
D O I
10.1007/s11739-022-02944-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1243 / 1245
页数:3
相关论文
共 50 条
  • [1] SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients series
    Mattia Zampieri
    Alessia Argirò
    Marco Allinovi
    Federico Perfetto
    Francesco Cappelli
    Internal and Emergency Medicine, 2022, 17 : 1243 - 1245
  • [2] “SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients series” comment
    Dimitrios Patoulias
    Christodoulos Papadopoulos
    Michael Doumas
    Internal and Emergency Medicine, 2022, 17 : 1553 - 1554
  • [3] "SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients series" comment
    Patoulias, Dimitrios
    Papadopoulos, Christodoulos
    Doumas, Michael
    INTERNAL AND EMERGENCY MEDICINE, 2022, 17 (05) : 1553 - 1554
  • [4] Real-World Efficacy of Tafamidis in Patients With Transthyretin Amyloidosis and Heart Failure
    Ghoneem, Ahmed
    Bhatti, Ammar W.
    Khadke, Sumanth
    Mitchell, Joshua
    Liu, Jennifer
    Zhang, Kathleen
    Trachtenberg, Barry
    Wechalekar, Ashutosh
    Cheng, Richard K.
    Baron, Suzanne J.
    Nohria, Anju
    Lenihan, Daniel
    Ganatra, Sarju
    Dani, Sourbha S.
    CURRENT PROBLEMS IN CARDIOLOGY, 2023, 48 (06)
  • [5] Real-World Efficacy of Tafamidis in Patients With Transthyretin Amyloidosis and Heart Failure
    Ghoneem, Ahmed
    Bhatti, Ammar W.
    Mitchell, Joshua D.
    Liu, Jennifer
    Zhang, Kathleen
    Trachtenberg, Barry
    Wechalekar, Ashtoush
    Cheng, Richard
    Baron, Suzanne J.
    Nohria, Anju
    Lenihan, Daniel
    Dani, Sourbha
    Ganatra, Sarju
    CIRCULATION, 2022, 146
  • [6] Comparing treatment strategies for heart failure: a real-world analysis of adding ARNI or SGLT2i to older GDMT
    Amornritvanich, P.
    Numthavaj, P.
    Anothaisintawee, T.
    Tansawet, A.
    Thakkinstian, A.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [7] SGLT2i Prescribers Among CKD Patients: Trends in Real-World Data (RWD)
    Stavas, Joseph
    Butler, Emily L.
    Abdelhadi, Jenna
    Zhang, Tancy C.
    Rubens, Lexie
    Irwin, Debra E.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 573 - 573
  • [8] Effect on Renal Function of SGLT2i Treatment in Hospitalized Patients with Type 2 Diabetes-A Real-World Study
    Bashkin, Amir
    Kruzel-Davila, Etty
    Tzfoni, Itai
    DIABETES, 2023, 72
  • [9] Characteristics and treatment of contemporary real-world patients with cardiac transthyretin amyloidosis: a retrospective, multicenter, observational study
    Pfister, R. Roman
    Ney, S.
    Kindermann, I.
    Knebel, F.
    Luedike, P.
    Morbach, C.
    Polzin, A.
    Unsoeld, B.
    Yilmaz, A.
    Nies, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 153 - 153
  • [10] SGLT2i reduce arrhythmic events in heart failure patients with cardiac implantable electronic devices
    Mariani, Marco Valerio
    Lavalle, Carlo
    Palombi, Marta
    Pierucci, Nicola
    Trivigno, Sara
    D'Amato, Andrea
    Filomena, Domenico
    Cipollone, Pietro
    Laviola, Domenico
    Piro, Agostino
    Prosperi, Silvia
    Magliolo, Josefina
    Myftari, Vincenzo
    La Fazia, Vincenzo Mirco
    Severino, Paolo
    Chimenti, Cristina
    Badagliacca, Roberto
    Vizza, Carmine Dario
    ESC HEART FAILURE, 2025,